INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
InfuSystem Holdings, Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$13.74+0.34 (+2.54%)
Close on Oct 19, 2026
- Market cap
- $287.44M
- P/E (TTM)
- 33.5
- Dividend yield
- –
InfuSystem Holdings, Inc revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient Services and Device Solutions | $29.00M | $26.26M | $28.97M | $28.96M | $28.22M | $26.93M | $26.04M | $27.95M | $26.68M | $25.63M | $25.44M | $24.81M | 78.5% | +2.7% |
| Patient Services | $24.79M | $22.11M | $21.88M | $22.36M | $21.52M | $20.77M | $20.76M | $20.78M | $20.25M | $18.59M | $19.16M | $19.29M | 67.1% | +15.2% |
| Device Solutions | $13.96M | $13.22M | $15.95M | $16.07M | $16.26M | $15.82M | $14.89M | $16.53M | $15.19M | $15.12M | $14.28M | $14.22M | 37.8% | -14.1% |
By product or service
By region
From the segment and revenue-disaggregation notes of InfuSystem's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.